Studies have identified the risks and risks of low-dose aspirin.

The study conducted an investigation, as the global balance between risks and risks is not clear to the person taking aspirin. The team combined information from the analysis of all viable follow-up studies and randomized control studies.

The results of studies of low doses of aspirin in people without CVD were associated with a 17% decrease in the incidence of CVD (non-fatal heart attacks, non-fatal strokes or deaths, associated with cerebrovascular disease). Low doses of aspirin are associated with reduced risk of ductal bleeding by 47% and increased risk of intracranial bleeding by 34%.

“Risks and concerns are due to formal analysis decisions to straighten out aspirin in primary prevention,” said co-author Lee Smith, professor at the University of England Ruskin in the UK.

The authors pointed out that, regardless of those who had been assessed a lot of dozens of cases for health, crimson heart disease and bleeding, they proved to be weak and, therefore, not to blame, but the main factor in making a decision about stasis no low-dose aspirin.

https://newsyou. info/ keywords:.